For the latest on Phase 3 TRIUMPH trial progress, see our Retatrutide 2026 Phase 3 Update
Previously, administration of GC via oral, rectal, IV and IM routes was prohibited in-competition due to clear evidence of systemic effects however this ban has now been extended to include any in-competition injection of GC (e.g., intravenous, intramuscular, periarticular, intra-articular, peritendinous, intratendinous, epidural, intrathecal, intrabursal, intralesional (e.g., intrakeloid), intradermal, and subcutaneous)
(143) summed up GLP-1R agonists to treat obesity and prevent cardiovascular disease
Those who cannot tolerate injectable GLP-1 medications
Profiles of the Common GLP-1 Receptor Agonists Note: All may cause significant/severe GI symptoms including nausea, vomiting, retching, gastroparesis, abdominal bloating, and pain
Semaglutide+Glapp Benefits Forgetting shots Never miss a dose Nausea surprises Personalized relief tips Unpredictable appetite Hunger tracking made easy Mood swings Emotions linked to meds Fear side effects Early warning tracker Unsure what to eat Nutrition guidance tailored Semaglutide FAQ: Dosing, Side Effects, and How to Use What is the best app to track my Semaglutide injections
